Individual-specific statin causing myopathy

PreclinicalSmall molecule

LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Individual-specific statin causing myopathy is one of 11 small molecule programs targeting Myopathy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MyopathyActive, not recruiting

MyopathyPreclinical

Active, not recruiting

Competition

Competitive Landscape

12 competitors in Myopathy

#DrugCompanyPhaseTrials

Viagra

VViatris Specialty LLC

Approved

1 2

Zocor

OOrganon and Co

Approved

1 3

Deltasone

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

1 4

Mesnex

BBaxter Healthcare Corporation

Approved

—5

Acetadote

AArbor Pharmaceuticals, Inc.

Approved

—6

Cytoxan

BBaxter Healthcare Corporation

Approved

—7

Dantrium

AAultman Health Foundation

Phase 3

1 8

Salbutamol

GSK

Preclinical

1 9

Coenzyme Q10

MMclean Hospital

Preclinical

1 10

Individual-specific statin causing myopathy

LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Myopathy1 trial

Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design

Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·N/A·NCT01259791·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Individual-specific statin causing myopathy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Individual-specific statin causing myopathy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Individual-specific statin causing myopathy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Individual-specific statin causing myopathy

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Myopathy1 trial

References

Drug Info

Quick Facts

Related News